MEA Bladder Disorders Market - Industry Trends and Forecast to 2029

MEA Bladder Disorders Market - Industry Trends and Forecast to 2029

In the Middle East and Africa, the bladder disorders market is projected to register a substantial CAGR of 6.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2020, and the forecast period is 2022 to 2029

Market Segmentation
The Middle East and Africa Bladder disorders Market - By Type (Cystitis, Urinary Incontinence, Overactive Bladder, Interstitial Cystitis, Bladder Cancer), Treatment Type (Surgery, Medication, Non-surgical), End User (Hospitals, Clinics, Ambulatory Surgery Centres, Others), Distribution Channel (Direct, Retail), Country (Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East and Africa) – Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the Middle East and Africa bladder disorders market are:
• Rising R&D investments and Launch of novel therapies in upcoming years
• Growing geriatric population
• Strategic initiatives adopted by market players
• Increasing prevalence of bladder disorders

Market Players

The major companies which are operating in the Middle East and Africa Bladder Disorders Market are listed below:
• Medtronic
• Laborie
• Boston Scientific Corporation
• Pfizer Inc.
• Astellas Pharma Inc.
• KYORIN Pharmaceutical Co., Ltd. (A subsidiary of KYORIN Holdings, Inc.)
• Bristol-Myers Squibb Company
• Johnson & Johnson Services, Inc.
• Axonics, Inc.
• Merck & Co., Inc.
• Viatris Inc.
• Gaylord Chemical Company, L.L.C.
• Coloplast Corp, AbbVie Inc.
• Sun Pharmaceutical Industries Ltd.
• Zydus Group
• Urovant Sciences, among others.


Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.